Cell Therapies Getting Second Chance in Parkinson’s

June 16, 2017

(MedPage Today) – Two clinical trials using cell therapies to treat Parkinson’s disease, one using fetal tissue and one using cells derived from embryonic stem cells (ESCs), seek to learn from the mixed results of earlier work using fetal tissue to prove cells can deliver dopamine to Parkinson patients with fewer side effects and less “off” time than current therapy, researchers reported on a panel here.

Recommended Reading